 Histocompatibility Testing
"Histocompatibility Testing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
| Descriptor ID |
D006650
|
| MeSH Number(s) |
E01.370.225.812.385 E05.200.812.385 E05.478.594.385
|
| Concept/Terms |
Histocompatibility Testing- Histocompatibility Testing
- Histocompatibility Testings
- Testing, Histocompatibility
- Testings, Histocompatibility
- Crossmatching, Tissue
- Crossmatchings, Tissue
- Tissue Crossmatching
- Tissue Crossmatchings
- Tissue Typing
- Tissue Typings
- Typing, Tissue
- Typings, Tissue
HLA Typing- HLA Typing
- HLA Typings
- Typing, HLA
- Typings, HLA
|
Below are MeSH descriptors whose meaning is more general than "Histocompatibility Testing".
Below are MeSH descriptors whose meaning is more specific than "Histocompatibility Testing".
This graph shows the total number of publications written about "Histocompatibility Testing" by people in UAMS Profiles by year, and whether "Histocompatibility Testing" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2025 | 1 | 1 | 2 | | 2024 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 | | 2017 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 1990 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Histocompatibility Testing" by people in Profiles over the past ten years.
-
L?z?r-Moln?r E, Truax CM, Eiting MM, Jain D, Hurst D, Zukauckas K, Pearce A, Bergam S, Gardner S, Clayton F, Florido R, Stehlik J, Shah KS. First use of imlifidase desensitization in a highly sensitized heart and liver transplant candidate: A case report. Hum Immunol. 2025 Sep; 86(5):111584.
-
Sullivan HC, Jaramillo A, Gaitonde S, Murphey C, Pandey S, Liu C, Jindra P, Hidalgo LG, Weimer ET, Alquist CR, Morris GP, Bray RA. Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborative. Am J Transplant. 2025 Oct; 25(10):2048-2056.
-
Kongtim P, Vittayawacharin P, Zou J, Srour S, Shaffer B, Shapiro RM, Varma A, McGuirk J, Dholaria BR, McCurdy SR, DeZern AE, Bejanyan N, Bashey A, Furst S, Castagna L, Mariotti J, Ruggeri A, Bailen R, Teshima T, Xiao-Jun H, Bonfim C, Aung F, Cao K, Carpenter PA, Hamadani M, Askar M, Fernandez-Vina M, Girnita A, Ciurea SO. ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies. Transplant Cell Ther. 2024 12; 30(12):1139-1154.
-
Karafin MS, Schumacher C, Zhang J, Simpson P, Johnson ST, Pierce KL. Human leukocyte antigen (HLA)-incompatible mean fluorescence intensity-selected platelet products have corrected count increments similar to HLA antigen-matched platelets. Transfusion. 2021 08; 61(8):2307-2316.
-
Keeshan BC, O'Connor MJ, Lin KY, Monos D, Lind C, Mascio CE, Rame JE, Spray TL, Shaddy RE, Rossano JW. Value of a flow cytometry cross-match in the setting of a negative complement-dependent cytotoxicity cross-match in heart transplant recipients. Clin Transplant. 2017 Oct; 31(10).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|